A day after he suggested that more pharma compes should be allowed to manufacture the COVID-19 vaccine, Union Minister Nitin Gadkari clarified that he was unaware of a speech made by Union Minister Mansukh Mandaviya that explained government's efforts to ramp up vaccine production.
Gadkari, in his series of tweet, said after his remark at the conference, Mandaviya informed him about 12 different plants and compes which has been facilitated by the Centre for vaccine manufacturing.
"Yesterday while participating at the conference orgsed by Swadeshi Jagaran Manch, I had made a suggestion to ramp up vaccine production. I was unaware that before my speech Minister for Chemical and Fertilizers @mansukhmandviya had explained government's efforts to ramp up vaccine production," Gadkari tweeted.
"After the conference, he also informed me that, GoI is already facilitating vaccine manufacturing by 12 different plants/compes and rapid ramp-up of production is expected in near future as a result of these efforts," he said in his tweet.
He further tweeted, "I was unaware that his ministry has started these efforts before I had given suggestions yesterday. I am glad and congratulate him and his team for this timely intervention in the right direction. I feel important to put this on record."
Earlier, while addressing a meeting via video conferencing, Gadkari said that more pharma compes should be allowed to manufacture the COVID-19 vaccine in the country during the pandemic to scale up production.
"If the demand for the vaccine is more than the supply, it creates the problem. So, instead of one company, let 10 more compes be given the license to manufacture the vaccine," the Union Minister said in his address yesterday.
"There are 2-3 laboratories in every state. They should be given the formula to produce the COVID-19 vaccines. They can give royalty," Gadkari said.
Currently, only two firms - Bharat Biotech and Serum Institute of India - are manufacturing COVID vaccines in the country and only three vaccines have so far been approved to administered in India --- COVAXIN, COVESHIELD and Sputnik V.
Many states have complained about the shortage of COVID-19 vaccines.
A total of 18,58,09,302 doses of COVID-19 vaccines have been administered across the country since the vaccination drive began on January 16.
( With inputs from ANI )
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor